Profound Medical Corp. (PROF) DCF Valuation

Profound Medical Corp. (PROF) DCF Valuation
  • Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • Pré-Construídos Para Uso Rápido E Eficiente
  • Não É Necessária Experiência; Fácil De Seguir

Profound Medical Corp. (PROF) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to evaluate the intrinsic value of Profound Medical Corp.? Our PROF DCF Calculator integrates real-world data with comprehensive customization features, allowing you to refine your projections and enhance your investment strategies.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 2.9 5.1 4.8 4.6 5.0 5.9 6.9 8.2 9.7 11.4
Revenue Growth, % 0 72.61 -5.9 -2.79 7.75 17.92 17.92 17.92 17.92 17.92
EBITDA -8.7 -13.5 -19.9 -24.0 -18.6 -5.9 -6.9 -8.2 -9.7 -11.4
EBITDA, % -296.01 -266.92 -416.82 -518.4 -372.01 -100 -100 -100 -100 -100
Depreciation 1.4 1.4 1.6 1.4 .8 1.9 2.2 2.6 3.0 3.6
Depreciation, % 47.59 28.24 34.28 31.26 15.92 31.46 31.46 31.46 31.46 31.46
EBIT -10.1 -15.0 -21.5 -25.5 -19.4 -5.9 -6.9 -8.2 -9.7 -11.4
EBIT, % -343.6 -295.17 -451.1 -549.66 -387.93 -100 -100 -100 -100 -100
Total Cash 10.2 58.2 46.6 32.3 18.2 5.9 6.9 8.2 9.7 11.4
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.8 5.2 1.0 4.4 5.1
Account Receivables, % 61.16 101.74 20.54 94.96 101.24
Inventories 2.5 3.7 5.1 5.5 4.9 5.4 6.3 7.5 8.8 10.4
Inventories, % 86.19 72.99 107.86 118.86 97.08 91.25 91.25 91.25 91.25 91.25
Accounts Payable 2.1 2.3 2.2 1.4 2.3 2.8 3.3 3.9 4.6 5.5
Accounts Payable, % 71.56 46.3 46.27 30.43 45.59 48.03 48.03 48.03 48.03 48.03
Capital Expenditure -.1 -.2 -.4 .0 .0 -.2 -.2 -.3 -.3 -.4
Capital Expenditure, % -4.52 -4.79 -8.63 0 0.000002705921 -3.59 -3.59 -3.59 -3.59 -3.59
Tax Rate, % 0.44604 0.44604 0.44604 0.44604 0.44604 0.44604 0.44604 0.44604 0.44604 0.44604
EBITAT -10.2 -15.0 -21.6 -25.7 -19.3 -5.9 -6.9 -8.2 -9.7 -11.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -11.2 -18.1 -17.8 -28.9 -17.6 -3.6 -6.3 -7.4 -8.7 -10.3
WACC, % 8.49 8.49 8.49 8.49 8.48 8.49 8.49 8.49 8.49 8.49
PV UFCF
SUM PV UFCF -27.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -10
Terminal Value -161
Present Terminal Value -107
Enterprise Value -135
Net Debt -13
Equity Value -122
Diluted Shares Outstanding, MM 21
Equity Value Per Share -5.77

What You Will Get

  • Comprehensive PROF Financials: Access to both historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Real-Time Calculations: Dynamic computation of intrinsic value and NPV.
  • Scenario Analysis: Evaluate various scenarios to assess Profound Medical's future performance.
  • User-Friendly Design: Crafted for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive PROF Data: Pre-loaded with Profound Medical Corp.'s historical financial metrics and future projections.
  • Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax assumptions, and capital expenditures.
  • Dynamic Valuation Framework: Instant updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
  • Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation results.
  • Intuitive Interface: Clean, organized, and tailored for both seasoned professionals and newcomers.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Profound Medical Corp.'s (PROF) preloaded data.
  • 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures as needed.
  • 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV in real-time.
  • 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation outcomes.
  • 5. Utilize with Assurance: Present professional valuation insights to bolster your decision-making process.

Why Choose Profound Medical Corp. (PROF)?

  • Innovative Solutions: Cutting-edge technology designed to enhance patient care and outcomes.
  • Proven Results: Clinical evidence supports the effectiveness of our treatments.
  • Patient-Centric Approach: Focused on improving the quality of life for patients through personalized care.
  • Expert Team: Our professionals are leaders in the field, ensuring high standards and expertise.
  • Commitment to Research: Ongoing investment in research and development to stay at the forefront of medical advancements.

Who Should Use Profound Medical Corp. (PROF)?

  • Healthcare Investors: Make informed investment choices with cutting-edge medical technology insights.
  • Medical Analysts: Streamline your analysis with comprehensive data on innovative treatment solutions.
  • Consultants: Easily modify presentations or reports to showcase the latest advancements in medical procedures.
  • Healthcare Enthusiasts: Enhance your knowledge of medical innovations through case studies and real-world applications.
  • Educators and Students: Utilize it as a hands-on resource in healthcare and medical technology courses.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations specific to Profound Medical Corp. (PROF).
  • Real-World Data: Profound Medical’s historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for deeper insights into Profound Medical's performance.
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage tailored to Profound Medical Corp. (PROF).
  • Dashboard with Visual Outputs: Charts and tables for clear, actionable results related to Profound Medical Corp. (PROF).